Hippocampal volume as treatment predictor in antidepressant naïve patients with major depressive disorder. (August 2021)

• Record Type: Journal Article
• Authors: Zarate-Garza, Pablo Patricio; Ortega-Balderas, Jessica Alejandra; Ontiveros-Sanchez de la Barquera, Jose Alfonso; Lugo-Guillen, Roberto Alejandro; Marfil-Rivera, Alejandro; Quiroga-Garza, Alejandro; Guzman-Lopez, Santos; Elizondo-Omaña, Rodrigo Enrique
• Is Part Of: Journal of psychiatric research. Volume 140(2021)
• Page Start: 323
• Page End: 328
• Publication Date: 2021-08
• Subjects: Major depressive disorder -- Hippocampal volume -- Naïve antidepressant -- Treatment outcome -- Remission -- Predictor; Psychiatry -- Periodicals; Mental Disorders -- Periodicals; Maladies mentales -- Périodiques; Psychiatry; Electronic journals; Periodicals; 616.89005
• DOI: 10.1016/j.jpsychires.2021.06.008
• Languages: English
• ISSNs: 0022-3956

Abstract

Abstract: Major depression disorder (MDD) limits psychosocial functioning and quality of life. One of the biological alterations is a hippocampal volume (HV) reduction. Previous prospective neuroimaging studies present inconsistencies regarding HV reductions and clinical features and response of antidepressant treatment of the participants. To clarify the relationship between antidepressant response and the HV reported, we prospectively evaluated antidepressant-naïve subjects diagnosed with MDD for the first time. We recruited twenty-one subjects and applied the Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), Beck Depression Inventory (BDI), and the Clinical Global Impression (CGI) scale. The participants underwent brain Magnetic Resonance Imaging (MRI) scanning to measure the HV, and subsequently were treated naturalistically with first-line antidepressant medication for eight weeks. Thirteen subjects met the criteria for remission at eight weeks of treatment. The baseline right and left hippocampal volumes were larger in subjects who achieved remission (p = 0.012) and (p = 0.001), respectively. The main finding of this study is that the antidepressant naïve subjects who met the criteria for clinical remission according to the HAM-D, MADRS, and the CGI scale scores, had larger pretreatment hippocampal volumes. Our results assess the HV as a treatment outcome predictor. Highlights: A longitudinal study of hippocampal volume as an outcome predictor for depression. Antidepressant naïve subjects had larger pretreatment hippocampal volume. Hippocampal volumes of non-remitters were statistically different than remitters.